Maximizing GI Practice Profitability: An Operational Playbook
Gastroenterology has more profit levers than most specialties: endoscopy volume, ASC ownership, infusion services, and ancillary revenue. The practices that structure operations well capture most of them.
The GI Business Model
Revenue Streams
- Professional services Office visits, consults
- Endoscopy procedures Colonoscopy, EGD, ERCP
- Facility fees If ASC-owned
- Infusion services Biologics for IBD
- Pathology If lab ownership
- Clinical research Pharma-sponsored trials
The Endoscopy Engine
Endoscopy is the profit center:
- Colonoscopy: $300-800 professional fee
- ASC facility fee: $1,000-2,500 additional
- Volume potential: 4-6 procedures per half-day block
Endoscopy Suite Optimization
Scheduling Efficiency
Maximize throughput:
- 30-minute procedure slots for screening colonoscopy
- 45-minute slots for complex/therapeutic
- Stagger patient arrivals
- Parallel processing in prep and recovery
Room Utilization
Target metrics:
- 85%+ room utilization
- <15 minute turnover
- <10% case cancellation
- First case on-time start >90%
Staffing Model
Per-room staffing:
- 2 RNs/procedure room
- 1 tech per room
- Shared recovery staff
- Front desk support
ASC Ownership in GI
The Financial Case
GI ASC economics:
- Average net per colonoscopy: $800-1,200
- Break-even: Often 2,500-3,500 procedures/year
- Typical margin: 30-45%
Ownership Structures
Options to consider:
- 100% physician-owned
- Joint venture with hospital
- Management company partnership
- Syndicated with other specialties
Regulatory Compliance
Critical requirements:
- State licensure
- Medicare certification
- Accreditation (AAAHC, JCAHO)
- Infection control standards
Infusion Services
The Biologics Opportunity
IBD biologics represent significant revenue:
- Infliximab, vedolizumab, ustekinumab
- Professional fee: $150-300
- Drug margin: Varies by 340B status and payer
- Patient convenience factor
Setting Up Infusion
Requirements:
- Dedicated infusion space
- RN staffing (1:3-4 patient ratio)
- Emergency protocols
- Drug inventory management
Buy-and-Bill vs. Specialty Pharmacy
Evaluate carefully:
- Payer mix matters enormously
- 340B eligibility changes economics
- Administrative burden of buy-and-bill
- White bagging trends
Clinical Operations
Office Visit Efficiency
Balance volume and quality:
- New GI consult: 30-45 minutes
- Follow-up: 15-20 minutes
- IBD complex: 30 minutes
- Procedure consent: Bundle with visit
MA Scope of Practice
Train MAs for GI-specific tasks:
- Medication reconciliation (complex in GI)
- Prior auth initiation
- Patient education
- Procedure prep instructions
Revenue Cycle for GI
Key Focus Areas
- Procedure coding accuracy Modifier usage critical
- Pathology coordination Ensure billing integration
- Biologic authorization High-dollar, high-scrutiny
- Screening vs. diagnostic coding Impacts patient cost-sharing
Common Coding Issues
- Colonoscopy with polypectomy coding
- Moderate sedation billing
- Specimen handling charges
- Split reimbursement scenarios
Quality and Outcomes
Key GI Metrics
- Adenoma detection rate (target >25%)
- Cecal intubation rate (target >95%)
- Complication rates
- Patient satisfaction
MIPS Considerations
GI-specific measures available:
- Colorectal cancer screening
- Barrett's surveillance
- Hepatitis C screening
- IBD assessment measures
Growth Strategies
Geographic Expansion
- Satellite endoscopy centers
- Clinic-only locations in underserved areas
- Hospital partnerships for complex procedures
Service Line Development
Consider adding:
- Hepatology focus
- Motility services
- Nutrition counseling
- Advanced endoscopy (EUS, ERCP if trained)
Endoscopy throughput and anesthesia arrangements carry most of the margin in a GI practice. Schedule a discovery call to review yours.
About the author
Managing Partner
Peter Kemp is a healthcare operations executive with more than 15 years of leadership experience spanning physician practice management, private-equity–backed startups, and multispecialty clinical organizations.
Read full bio